-- EBR Systems (ASX:EBR) received priority review determination from the Therapeutic Goods Administration for the WiSE System, according to a Friday filing with the Australian bourse.
The WiSE System is a cardiac device capable of pacing the heart without a lead.
The determination provides an accelerated pathway for the device to be included on the Australian Register of Therapeutic Goods, the filing said.
Shares rose 7% in morning trade on Friday.